All Pharma News
Diversifying the Supply of Raw Materials

Diversifying the Supply of Raw Materials
PRESS RELEASE
12 Jun 2024
Share Share
Noramco Announces Strategic Alignment with Purisys and Halo Pharma, Launching the Noramco Group as an Integrated North American-Based API and Drug Product Supply Chain Services Provider

Noramco Announces Strategic Alignment with Purisys and Halo Pharma, Launching the Noramco Group as an Integrated North American-Based API and Drug Product Supply Chain Services Provider
BUSINESSWIRE
15 Mar 2024
Share Share
Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit

Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit
PRESS RELEASE
02 Nov 2023
Share Share
Noramco Announces Submission & Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide

Noramco Announces Submission & Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide
PRESS RELEASE
01 Nov 2022
Share Share
Noramco Celebrates Diversity and International Women’s Day

Noramco Celebrates Diversity and International Women’s Day
Randolph Ramirez PRESS RELEASE
07 Mar 2022
Share Share
Noramco Announces Submission of DMF for Lisdexamfetamine Dimesylate

Noramco Announces Submission of DMF for Lisdexamfetamine Dimesylate
BUSINESSWIRE
03 Dec 2021
Share Share
Noramco celebrates Hamilton branch grand opening

Noramco celebrates Hamilton branch grand opening
Anthony Capkun EBMAG
10 Nov 2021
Share Share
GB Sciences and Purisys Announce Preferred Supplier Relationship

GB Sciences and Purisys Announce Preferred Supplier Relationship
YAHOO
20 Apr 2021
Share Share
RespireRx Pharmaceuticals Inc. Announces Extension to Long-Term Employment Contract with Tim Jones as President and Chief Executive Officer

RespireRx Pharmaceuticals Inc. Announces Extension to Long-Term Employment Contract with Tim Jones as President and Chief Executive Officer
GLOBENEWSWIRE
03 Aug 2020
Share Share
RespireRx Pharmaceuticals Appoints Timothy Jones as CEO

RespireRx Pharmaceuticals Appoints Timothy Jones as CEO
NEWYORK
09 May 2020
Share Share